Purple Innovation Reports First Quarter 2025 Results; Reaffirms 2025 Guidance
- Significant expansion with Mattress Firm, more than doubling retail presence from 5,000 to 12,000 mattress slots
- GAAP gross margin improved 460 basis points to 39.4%; Adjusted gross margin up 550 basis points to 40.3%
- Operating expenses decreased 14.4% to $55.5 million through restructuring efforts
- Net loss improved significantly from $(50.2) million to $(19.1) million year-over-year
- Secured additional $20 million in financing through Term Loan amendment
- Q1 revenue declined 13.2% to $104.2 million year-over-year
- Cash position decreased from $29.0 million to $21.6 million since December 2024
- Negative Adjusted EBITDA of $(4.7) million in Q1
- Ongoing uncertainty around timing and scope of tariffs impacting business outlook
- Continued macroeconomic challenges affecting wholesale and ecommerce demand
Insights
Purple's Q1 showed revenue decline but margin improvements, with a major Mattress Firm expansion potentially offsetting current sales weakness.
Purple Innovation's Q1 results present a company in transition, making operational progress despite revenue headwinds. Revenue declined 13.2% to
The expanded Mattress Firm partnership represents a potential game-changer, more than doubling Purple's retail footprint from approximately 5,000 to at least 12,000 mattress slots nationwide. This significant distribution expansion required additional capital, explaining the
Financially, Purple's balance sheet shows some pressure with cash decreasing from
Management's reaffirmation of 2025 guidance (
Purple's expanded Mattress Firm partnership creates massive distribution upside while balancing near-term sales weakness and operational restructuring.
Purple's Q1 results reveal the challenging dynamics facing specialty bedding retailers, with top-line pressure (
The announcement of Purple's expanded partnership with Mattress Firm represents a strategic retail breakthrough. By securing over 12,000 mattress slots across Mattress Firm locations (up from 5,000), Purple gains significantly enhanced visibility in the nation's largest specialty mattress retailer. This expanded placement will dramatically increase Purple's addressable market and brand exposure while providing a buffer against e-commerce volatility.
The manufacturing arrangement with Tempur Sealy subsidiary Tempur Sherwood is equally noteworthy – Purple maintains production of its proprietary gel grid technology (its key differentiator) while outsourcing assembly of specific product lines. This hybrid approach allows Purple to maintain quality control of its core technology while leveraging Tempur Sealy's manufacturing scale and efficiency for the expanded Mattress Firm rollout.
The Purple-Mattress Firm-Tempur Sealy triangle creates an interesting dynamic where competitors are also collaborators, reflecting the complex ecosystem of today's mattress industry. For Purple, this arrangement provides distribution scale and manufacturing support while reducing capital requirements, though execution of this complex partnership will be crucial to realizing its potential benefits.
Exceeded Q1 Adjusted EBITDA Target; Delivered Q1 Sales Consistent with Guidance
GAAP Gross Margin of
"Our first quarter performance reflects continued progress against our strategic priorities to stabilize and strengthen the business, and position Purple for long-term success," said Rob DeMartini, CEO of Purple Innovation. "Revenue was in line with expectations, led by positive showroom growth, while continued improvement in gross margin and cost control drove Adjusted EBITDA ahead of guidance."
DeMartini continued, "As we move forward, our focus is on unlocking growth through continued innovation, including the full rollout of our Rejuvenate 2.0 collection, promoting our unique Gel Grid differentiation, and further optimizing our operations. Though the current economic environment remains uncertain, including the evolving impact of tariffs, we believe the structural improvements we have achieved, and investments we have made across innovation and partnership expansion, position us to navigate near-term pressures and deliver sustained growth over time."
First Quarter 2025 Financial Results
First quarter 2025 net revenue declined by
Gross profit for the first quarter decreased slightly to
Operating expenses for the first quarter were
Net loss attributable to Purple Innovation, Inc. for the first quarter was
Adjusted EBITDA for the first quarter was
Balance Sheet
As of March 31, 2025, the Company had cash and cash equivalents of
Inventories as of March 31, 2025 totaled
2025 Outlook
The Company is reiterating its 2025 outlook for full year revenue to be in the range of
Mattress Firm Update
Today, the Company announced a significant expansion of its commercial partnership with Mattress Firm, through an agreement with Somnigroup International, Inc. Under the terms of this multifaceted agreement, Purple will more than double its retail footprint in Mattress Firm stores nationwide through the second half of 2025, from approximately 5,000 mattress slots to a minimum of 12,000 mattress slots. The agreement also expands the existing strategic supply relationship with Tempur Sherwood, LLC, a subsidiary of Tempur Sealy, which will have the exclusive right to assemble certain product lines that Purple sells to Mattress Firm. Purple will maintain production of its proprietary grid technology and retain all related intellectual property. These expanded partnerships are a clear endorsement of Purple's product differentiation and brand strength, and enable further investment in driving innovation, brand visibility, and top-line growth.
Term Loan Amendment
Subsequent to quarter-end, Purple successfully borrowed an incremental
Conference Call and Webcast Information
Purple Innovation, Inc. will host a live conference call to discuss financial results today, May 6, 2025 at 4:30 p.m. Eastern Time. To access the call dial 800-715-9871 (domestic) or 646-307-1963 (international). The call is also being webcast and can be accessed on the investor relations section of the Company's website, investors.purple.com. After the conference call, a webcast replay will remain available on the investor relations section of the Company's website for 30 days.
About Purple
Purple, the leading premium mattress company with the #1 Gel Grid technology in the world, the GelFlex® Grid, thoughtfully engineers products that make restorative sleep effortless for every kind of sleeper. The result of over 30 years of innovation and in comfort technologies, Purple's GelFlex Grid is the most significant advancement in mattresses in decades and is proven to reduce aches and pains. It instantly adapts as you move, balances temperature, relieves pressure and offers support in all the right places. Purple products, including mattresses, pillows, cushions, frames, sheets, and more, can be found online at Purple.com, in 55 Purple stores and over 3,000 retailers nationwide. Sleep Better. Live Purple.
Forward Looking Statements
Certain statements made in this release that are not historical facts are "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Statements based on historical data are not intended and should not be understood to indicate the Company's expectations regarding future events. Forward-looking statements provide current expectations or forecasts of future events or determinations. These statements include, but are not limited to, statements regarding our innovation pipeline, the timing of new product collection launches, our ability to improve profitability and optimize our business, and the future expansion of and benefits to us from our commercial relationships with Somnigroup International, Inc. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Factors that could influence the realization of forward-looking statements include, among others: changes in economic, financial and end-market conditions in the markets in which we operate; fluctuations in raw material prices and cost of labor; the financial condition of our customers and suppliers; competitive pressures, including the need for technology improvement, successful new product development and introduction; changes in consumer demand, including pullbacks in consumer spending; disruptions to our manufacturing processes; and the risk factors outlined in the "Risk Factors" section of our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 14, 2025, and in our other filings made with the SEC. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Non-GAAP Financial Measures
EBITDA, adjusted gross margin, adjusted EBITDA, adjusted net income, and adjusted net income per diluted share are non-GAAP financial measures that remove the impact of certain non-cash and non-recurring costs. Management believes that the use of such non-GAAP financial measures provides investors with additional useful information with respect to the impact of various adjustments, which we view as a better measure of our operating performance. Refer to the attached table for the reconciliation of such non-GAAP financial measures to the most comparable GAAP financial measure.
With respect to the Company's Adjusted EBITDA outlook for the full year 2025, a quantitative reconciliation to the corresponding GAAP information cannot be provided without unreasonable effort because of the inherent difficulty of accurately forecasting the occurrence and financial impact of the various adjusting items necessary for such reconciliation that have not yet occurred, are out of our control, or cannot be reasonably predicted, including but not limited to warrant liabilities and stock based compensation. For the same reasons, the Company is unable to assess the probable significance of the unavailable information, which could have a material impact on its future GAAP financial results.
Investor Contact:
Stacy Turnof, Edelman Smithfield
stacy.turnof@edelmansmithfield.com
917-362-2581
PURPLE INNOVATION, INC. Condensed Consolidated Balance Sheets (unaudited - in thousands, except par value) | ||||||||
March 31, | December 31, | |||||||
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 21,627 | $ | 29,011 | ||||
Accounts receivable, net | 24,388 | 33,057 | ||||||
Inventories | 60,177 | 56,863 | ||||||
Prepaid expenses | 5,582 | 6,023 | ||||||
Other current assets | 1,627 | 1,414 | ||||||
Total current assets | 113,401 | 126,368 | ||||||
Property and equipment, net | 90,433 | 93,874 | ||||||
Operating lease right-of-use assets | 77,817 | 75,516 | ||||||
Intangible assets, net | 8,215 | 8,890 | ||||||
Other long-term assets | 3,906 | 3,197 | ||||||
Total assets | $ | 293,772 | $ | 307,845 | ||||
Liabilities and Stockholders' Equity | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 32,356 | $ | 40,639 | ||||
Accrued compensation | 7,445 | 9,415 | ||||||
Customer prepayments | 3,726 | 6,411 | ||||||
Accrued rebates and allowances | 6,159 | 10,013 | ||||||
Accrued warranty liabilities – current portion | 7,351 | 6,114 | ||||||
Operating lease obligations – current portion | 15,904 | 15,661 | ||||||
Other current liabilities | 10,672 | 12,750 | ||||||
Total current liabilities | 83,613 | 101,003 | ||||||
Related party debt | 72,737 | 55,394 | ||||||
Accrued warranty liabilities, net of current portion | 24,367 | 26,091 | ||||||
Operating lease obligations, net of current portion | 88,281 | 87,072 | ||||||
Warrant liabilities | 21,414 | 16,067 | ||||||
Other long-term liabilities | 2,030 | 2,009 | ||||||
Total liabilities | 292,442 | 287,636 | ||||||
Commitments and contingencies (Note 13) | ||||||||
Stockholders' equity: | ||||||||
Class A common stock; | 11 | 11 | ||||||
Class B common stock; | — | — | ||||||
Additional paid-in capital | 594,332 | 594,053 | ||||||
Accumulated deficit | (593,003) | (573,866) | ||||||
Total stockholders' equity attributable to Purple Innovation, Inc. | 1,340 | 20,198 | ||||||
Noncontrolling interest | (10) | 11 | ||||||
Total stockholders' equity | 1,330 | 20,209 | ||||||
Total liabilities and stockholders' equity | $ | 293,772 | $ | 307,845 | ||||
PURPLE INNOVATION, INC. Condensed Consolidated Statements of Income (unaudited - in thousands, except per share amounts) | ||||||||
Three Months Ended | ||||||||
2025 | 2024 | |||||||
Revenues, net | $ | 104,171 | $ | 120,033 | ||||
Cost of revenues: | ||||||||
Cost of revenues | 62,207 | 78,313 | ||||||
Cost of revenues - restructuring related charges | 918 | — | ||||||
Total cost of revenues | 63,125 | 78,313 | ||||||
Gross profit | 41,046 | 41,720 | ||||||
Operating expenses: | ||||||||
Marketing and sales | 36,626 | 41,462 | ||||||
General and administrative | 14,487 | 19,728 | ||||||
Research and development | 2,452 | 3,666 | ||||||
Restructuring, impairment and other related charges | 1,960 | — | ||||||
Total operating expenses | 55,525 | 64,856 | ||||||
Operating loss | (14,479) | (23,136) | ||||||
Other income (expense): | ||||||||
Interest expense | (4,764) | (4,474) | ||||||
Other income, net | 69 | 4,394 | ||||||
Gain (loss) on extinguishment of debt | — | (3,394) | ||||||
Change in fair value – warrant liabilities | 49 | (23,599) | ||||||
Total other income (expense), net | (4,646) | (27,073) | ||||||
Net loss before income taxes | (19,125) | (50,209) | ||||||
Income tax expense | (41) | (59) | ||||||
Net loss | (19,166) | (50,268) | ||||||
Net loss attributable to noncontrolling interest | (29) | (51) | ||||||
Net loss attributable to Purple Innovation, Inc. | $ | (19,137) | $ | (50,217) | ||||
Net loss per share: | ||||||||
Basic | $ | (0.18) | $ | (0.47) | ||||
Diluted | $ | (0.18) | $ | (0.47) | ||||
Weighted average common shares outstanding: | ||||||||
Basic | 107,596 | 106,022 | ||||||
Diluted | 107,596 | 106,022 | ||||||
PURPLE INNOVATION, INC. Condensed Consolidated Statements of Cash Flows (unaudited - in thousands) | ||||||||
Three Months Ended | ||||||||
2025 | 2024 | |||||||
Cash flows from operating activities: | ||||||||
Net loss | $ | (19,166) | $ | (50,268) | ||||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization | 5,050 | 6,382 | ||||||
Non-cash interest | 2,120 | 1,563 | ||||||
Paid-in-kind interest | 2,789 | 1,850 | ||||||
Non-cash restructuring, impairment and other related charges | 635 | — | ||||||
Loss on extinguishment of debt | — | 3,394 | ||||||
Loss on disposal of property and equipment | 88 | 112 | ||||||
Change in fair value – warrant liabilities | (49) | 23,599 | ||||||
Stock-based compensation | 368 | 492 | ||||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | 8,669 | 10,060 | ||||||
Inventories | (3,314) | (5,150) | ||||||
Prepaid expenses and other assets | 2,229 | 66 | ||||||
Operating leases, net | (848) | (209) | ||||||
Accounts payable | (9,701) | (7,043) | ||||||
Accrued compensation | (1,970) | 4,724 | ||||||
Customer prepayments | (2,685) | (1,724) | ||||||
Accrued rebates and allowances | (3,854) | (4,717) | ||||||
Accrued warranty liabilities | (487) | 368 | ||||||
Other accrued liabilities | (2,944) | (313) | ||||||
Net cash used in operating activities | (23,070) | (16,814) | ||||||
Cash flows from investing activities: | ||||||||
Sale of property and equipment | 258 | — | ||||||
Purchase of property and equipment | (2,241) | (3,038) | ||||||
Investment in intangible assets | (161) | (62) | ||||||
Net cash used in investing activities | (2,144) | (3,100) | ||||||
Cash flows from financing activities: | ||||||||
Proceeds from related party loan | 19,000 | 61,000 | ||||||
Payments on term loan | — | (25,000) | ||||||
Payments on revolving line of credit | — | (5,000) | ||||||
Payments for debt issuance costs | (1,170) | (3,466) | ||||||
Net cash provided by financing activities | 17,830 | 27,534 | ||||||
Net increase (decrease) in cash, cash equivalents and restricted cash | (7,384) | 7,620 | ||||||
Cash and cash equivalents, beginning of the year | 29,011 | 26,857 | ||||||
Cash and cash equivalents, end of the period | $ | 21,627 | $ | 34,477 | ||||
PURPLE INNOVATION, INC.
RECONCILIATION OF GAAP TO NON-GAAP MEASURES
(In thousands)
Management believes that the use of the following non-GAAP financial measures provides investors with additional useful information with respect to the impact of various adjustments, which we view as a better measure of our operating performance. These non-GAAP financial measures are EBITDA, adjusted EBITDA, adjusted net loss, and adjusted net loss per diluted share. Other companies may calculate these non-GAAP measures differently than we do. These non-GAAP measures have limitations as analytical tools, and you should not consider them in isolation or as a substitute for our financial results prepared in accordance with GAAP.
Reconciliation of GAAP Net Loss to Non-GAAP EBITDA and Adjusted EBITDA
A reconciliation of GAAP net loss to the non-GAAP measures of EBITDA and adjusted EBITDA is provided below. EBITDA represents net loss before interest expense, income tax (benefit) expense, other income, net, and depreciation and amortization. Adjusted EBITDA represents EBITDA excluding costs incurred due to changes in the fair value of the warrant liability, stock-based compensation expense, restructuring related charges, nonrecurring legal fees, Board special committee costs, executive interim and search costs, severance costs and showroom opening and closing costs. We believe EBITDA and Adjusted EBITDA provide additional useful information with respect to the impact of various adjustments and provide meaningful measures of our operating performance.
Three Months Ended March 31, | ||||||||
2025 | 2024 | |||||||
GAAP net loss | $ | (19,166) | (50,268) | |||||
Interest expense | 4,764 | 4,474 | ||||||
Income tax expense | 41 | 59 | ||||||
Other income, net | (69) | (4,394) | ||||||
Depreciation and amortization | 5,050 | 6,382 | ||||||
EBITDA | (9,380) | (43,747) | ||||||
Adjustments: | ||||||||
Change in fair value - warrant liability | (49) | 23,599 | ||||||
Loss on extinguishment of debt | — | 3,394 | ||||||
Stock-based compensation expense | 406 | 492 | ||||||
Restructuring related charges | 2,648 | — | ||||||
Legal fees | 233 | 837 | ||||||
Board special committee fees | 174 | — | ||||||
Executive interim and search costs | — | 1,448 | ||||||
Severance costs | 1,209 | 780 | ||||||
Showroom opening/closing costs | 33 | 1 | ||||||
Adjusted EBITDA | $ | (4,726) | $ | (13,196) | ||||
Reconciliation of GAAP Gross Profit to Adjusted Gross Profit
A reconciliation of GAAP gross margin to the non-GAAP measures of adjusted gross margin is provided below. Adjusted gross profit represents net revenue less adjusted cost of revenue. Adjusted cost of revenues represents cost of revenues excluding restructuring charges recorded in cost of revenues. We believe adjusted gross profit provides additional useful information with respect to the impact of the restructuring and provides meaningful measures of our operating performance.
(in thousands) | Three Months Ended March 31, | |||||||
2025 | 2024 | |||||||
Revenues, net | $ | 104,171 | $ | 120,033 | ||||
Total cost of revenues | 63,125 | 78,313 | ||||||
Restructuring charges in cost of revenues | (918) | — | ||||||
Adjusted cost of revenues | 62,207 | 78,313 | ||||||
Adjusted gross profit | $ | 41,964 | $ | 41,720 | ||||
Adjusted gross profit % | 40.3 | % | 34.8 | % | ||||
Reconciliation of GAAP Net Loss to non-GAAP Adjusted Net Loss and Adjusted Net Loss per Diluted Share
Our presentation of adjusted net loss assumes that all net loss is attributable to Purple Innovation, Inc. (i.e. there is no allocation of net loss to noncontrolling interests), which assumes the full exchange at the beginning of the period of all outstanding Paired Securities for shares of Class A common stock of Purple Innovation, Inc., adjusted for certain nonrecurring items that we do not believe directly reflect our core operations. Adjusted net loss per share, diluted, is calculated by dividing adjusted net loss by the total shares of Class A common stock outstanding plus any dilutive warrants, options and restricted stock as calculated in accordance with GAAP and assuming the full exchange of all outstanding Paired Securities as of the beginning of each period presented. Adjusted net loss and adjusted net loss per diluted share, are supplemental measures of operating performance that do not represent, and should not be considered, alternatives to net loss and loss per share, as calculated in accordance with GAAP. We believe adjusted net loss and adjusted net loss per diluted share, supplement GAAP measures and enable us to more effectively evaluate our performance period-over-period. A reconciliation of net loss, the most directly comparable GAAP measure, to adjusted net loss and the computation of adjusted net loss per diluted share, are set forth below:
Three Months Ended | |||||||||
2025 | 2024 | ||||||||
Net loss | $ | (19,166) | $ | (50,268) | |||||
Income tax (benefit) expense, as reported | 41 | 59 | |||||||
Change in fair value – warrant liabilities | (49) | 23,599 | |||||||
Loss on extinguishment of debt | — | 3,394 | |||||||
Restructuring related charges | 2,878 | — | |||||||
Gain on insurance proceeds | — | (4,300) | |||||||
Board special committee fees | 174 | — | |||||||
Adjusted net loss before income taxes | (16,122) | (27,516) | |||||||
Adjusted income taxes(1) | 4,176 | 7,127 | |||||||
Adjusted net loss | $ | (11,946) | $ | (20,389) | |||||
Adjusted net income per share, diluted | $ | (0.11) | $ | (0.19) | |||||
Adjusted weighted-average shares outstanding, diluted(2) | 107,761 | 106,227 | |||||||
(1) Represents the estimated effective tax rate of |
(2) Assumes options and restricted stock units calculated in accordance with GAAP and the full exchange of all outstanding Paired Securities for shares of Class A common stock as of the beginning of the period. |
A reconciliation of net income (loss) per share, diluted, to adjusted net income per diluted share is set forth below for the three months ended March 31, 2025 and 2024:
For the Three Months Ended | ||||||||||||||||||||||||
March 31, 2025 | March 31, 2024 | |||||||||||||||||||||||
Net Loss | Weighted | Net Loss | Net Loss | Weighted | Net Loss | |||||||||||||||||||
Net loss attributable to Purple | $ | (19,137) | 107,596 | (0.18) | $ | (50,217) | 106,022 | $ | (0.47) | |||||||||||||||
Assumed exchange of shares(2) | (29) | 165 | (51) | 205 | ||||||||||||||||||||
Net loss | (19,166) | (50,268) | ||||||||||||||||||||||
Adjustments to arrive at adjusted net | 3,044 | 22,752 | ||||||||||||||||||||||
Adjusted net loss before taxes | (16,122) | (27,516) | ||||||||||||||||||||||
Adjusted income tax benefit(4) | 4,176 | 7,127 | ||||||||||||||||||||||
Adjusted net loss | $ | 11,946 | 107,761 | (0.11) | $ | (20,389) | 106,227 | $ | (0.19) | |||||||||||||||
(1) Represents net income attributable to Purple Innovation, Inc. and the associated weighted average diluted shares, of Class A common stock outstanding. |
(2) Assumes the full exchange of all outstanding Paired Securities for shares of Class A common stock as of the beginning of the period and added in if not already included in the weighted average diluted shares. Also assumes the addition of net income attributable to noncontrolling interests corresponding with the assumed exchange of the Paired Securities for shares of Class A common stock. |
(3) Represents the total impact of all adjustments identified in the adjusted net income table above to arrive at adjusted income before income taxes. Also assumes the dilutive warrants, options and restricted stock as calculated in accordance with GAAP. |
(4) Represents the estimated effective tax rate of |
View original content to download multimedia:https://www.prnewswire.com/news-releases/purple-innovation-reports-first-quarter-2025-results-reaffirms-2025-guidance-302447707.html
SOURCE Purple Innovation, LLC
FAQ
What was Purple Innovation's (PRPL) revenue in Q1 2025?
How many Mattress Firm stores will carry Purple products after the expansion?
What is Purple's (PRPL) revenue guidance for 2025?
How much did Purple's (PRPL) gross margin improve in Q1 2025?
How much additional funding did Purple (PRPL) secure through its Term Loan amendment?
